Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2005 3
2006 3
2007 1
2008 1
2009 2
2010 4
2011 6
2012 9
2013 10
2014 10
2015 14
2016 10
2017 13
2018 14
2019 11
2020 7
2021 5
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al.
Kiesslich T, Mayr C, Bekric D, Neureiter D. Kiesslich T, et al. Transl Oncol. 2024 Jun;44:101820. doi: 10.1016/j.tranon.2023.101820. Epub 2023 Nov 15. Transl Oncol. 2024. PMID: 38641373 Free article. No abstract available.
Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells.
Mayr C, Kiesslich T, Bekric D, Beyreis M, Kittl M, Ablinger C, Neureiter E, Pichler M, Prinz F, Ritter M, Neureiter D, Jakab M, Dobias H. Mayr C, et al. Among authors: kiesslich t. PLoS One. 2023 Jun 30;18(6):e0287769. doi: 10.1371/journal.pone.0287769. eCollection 2023. PLoS One. 2023. PMID: 37390071 Free PMC article.
HDACs as an emerging target in endocrine tumors: a comprehensive review.
Klieser E, Neumayer B, Di Fazio P, Mayr C, Neureiter D, Kiesslich T. Klieser E, et al. Among authors: kiesslich t. Expert Rev Endocrinol Metab. 2023 Mar;18(2):143-154. doi: 10.1080/17446651.2023.2183840. Epub 2023 Mar 6. Expert Rev Endocrinol Metab. 2023. PMID: 36872882 Review.
New method for real-time visualization and quantitative characterization of early colorectal cancer in endoscopy: a pilot study.
Wagner A, Zandanell S, Ziachehabi A, Mitrakov A, Klieser E, Neureiter D, Kiesslich T, Mayr C, Berr F, Fedoruk M, Singhartinger F, Holzinger J. Wagner A, et al. Among authors: kiesslich t. Endosc Int Open. 2022 Aug 15;10(8):E1147-E1154. doi: 10.1055/a-1847-2820. eCollection 2022 Aug. Endosc Int Open. 2022. PMID: 36082194 Free PMC article.
Can We Efficiently Target HDAC in Cancer?
Kiesslich T, Neureiter D. Kiesslich T, et al. Cancers (Basel). 2022 Aug 22;14(16):4058. doi: 10.3390/cancers14164058. Cancers (Basel). 2022. PMID: 36011050 Free PMC article.
119 results